MARKET

MMED

MMED

MINIMED GROUP INC
NASDAQ
13.92
+0.12
+0.87%
After Hours: 14.06 +0.14 +1.01% 18:51 04/10 EDT
OPEN
14.01
PREV CLOSE
13.80
HIGH
14.70
LOW
13.89
VOLUME
663.59K
TURNOVER
--
52 WEEK HIGH
20.48
52 WEEK LOW
12.80
MARKET CAP
3.91B
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
William Blair med tech analyst holds an analyst/industry conference call
TipRanks · 16h ago
Largest IPOs of the last 90 days register mixed debut
Seeking Alpha · 4d ago
Medtronic price target lowered to $95 from $105 at Stifel
TipRanks · 4d ago
Weekly Report: what happened at MMED last week (0330-0403)?
Weekly Report · 4d ago
A Look At Minimed Group (MMED) Valuation After Recent Share Price Weakness
Simply Wall St · 6d ago
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
Benzinga · 04/01 14:15
This Sensata Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga · 04/01 14:08
Minimed Group Price Target Announced at $26.00/Share by Barclays
Dow Jones · 04/01 13:57
More
About MMED
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.

Webull offers MiniMed Group, Inc. stock information, including NASDAQ: MMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MMED stock methods without spending real money on the virtual paper trading platform.